Compare OVID & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | AMTX |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.5M | 98.6M |
| IPO Year | 2017 | N/A |
| Metric | OVID | AMTX |
|---|---|---|
| Price | $1.60 | $1.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $3.40 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 1.7M | 1.1M |
| Earning Date | 03-10-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,610,000.00 | ★ $201,323,000.00 |
| Revenue This Year | $1,077.56 | N/A |
| Revenue Next Year | N/A | $139.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 945.89 | N/A |
| 52 Week Low | $0.24 | $1.22 |
| 52 Week High | $2.01 | $3.66 |
| Indicator | OVID | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 50.68 |
| Support Level | $1.40 | $1.55 |
| Resistance Level | $1.61 | $1.83 |
| Average True Range (ATR) | 0.12 | 0.15 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 15.91 | 38.89 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.